Prestige Consumer Healthcare (PBH)

• Market cap: $3.11B
• 1 day: -2.72%
• 5 days: -2.41%
• 1 month: -3.15%
• 3 months: -25.71%
• 6 months: -23.71%
• Year to date: -18.62%
• 1 year: -13.25%
• 5 years: 70.9%
• 10 years: 38.43%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Employees: 600

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

67% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 33

28% more repeat investments, than reductions

Existing positions increased: 150 | Existing positions reduced: 117

5% more funds holding

Funds holding: 356 [Q1] → 373 (+17) [Q2]

1.89% more ownership

Funds ownership: 103.33% [Q1] → 105.21% (+1.89%) [Q2]

6% less capital invested

Capital invested by funds: $4.4B [Q1] → $4.15B (-$246M) [Q2]

50% less funds holding in top 10

Funds holding in top 10: 4 [Q1] → 2 (-2) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $100
• Avg. target: $100
• High target: $100

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Canaccord Genuity Susan Anderson

$100

Buy Maintained

8 Aug 2025